Skip to main content
Erschienen in: Current Hepatology Reports 1/2017

21.02.2017 | Hepatic Cancer (A Singal and A Mufti, Section Editors)

Understanding LI-RADS, Its Relationship to AASLD and OPTN, and the Challenges of Its Adoption

verfasst von: Joseph H. Yacoub, Frank H. Miller

Erschienen in: Current Hepatology Reports | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Imaging-based diagnosis of hepatocellular carcinoma (HCC) is incorporated in many clinical guidelines on the management of HCC. However, there is variability in the diagnostic criteria for HCC and lack of precise definitions for imaging characteristics. With the intent of standardization and maintaining compatibility with the American Association for the Study of Liver Diseases (AASLD) and Organ Procurement and Transplantation Network (OPTN), the Liver Imaging Reporting and Data System (LI-RADS) was developed as a system for standardizing the performance, interpretation, and reporting of CT and MRI in patients at high risk of HCC. It precisely defines the terms and imaging features used in the diagnostic algorithm with the aid of a lexicon and illustrative atlas. While it is a comprehensive system, the challenges to its adoption are not trivial and can be controversial. A better understanding of the purpose and the limitation of the system can help in building consensus within and across disciplines. In this paper, we describe LI-RADS and its relationship to AASLD and OPTN guidelines. The LR-5 category is essentially equivalent to OPTN class 5 with few minor exceptions. LR-5 has been expanded to also encompass the AASLD definition of HCC. LR-4, LR-3, and LR-2 allow for more granular classification of indeterminate lesions. We highlight the advantages of the system and try to address the challenges that may impede or delay its adoption. We also review the emerging literature on its validation emphasizing that since LR-5 is designed to be specific, many HCCs will not meet LR-5 criteria and most of them will be LR-4.
Literatur
2.
Zurück zum Zitat Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, et al. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int. 2012;32:1053–63.CrossRefPubMed Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, et al. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int. 2012;32:1053–63.CrossRefPubMed
4.
5.
Zurück zum Zitat •• Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013;266:376–82. This papers details the improved imaging criteria for OPTN/UNOS update of 2011. CrossRefPubMed •• Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013;266:376–82. This papers details the improved imaging criteria for OPTN/UNOS update of 2011. CrossRefPubMed
6.
Zurück zum Zitat Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transplant. 2010;16:262–78.CrossRef Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transplant. 2010;16:262–78.CrossRef
7.
Zurück zum Zitat European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. Erratum to: “EASL–EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma” [J Hepatol 2012;56:]. J. Hepatol. 2012. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. Erratum to: “EASL–EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma” [J Hepatol 2012;56:]. J. Hepatol. 2012.
8.
Zurück zum Zitat Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339–64.CrossRefPubMed Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339–64.CrossRefPubMed
9.
Zurück zum Zitat Omata M, Lesmana LA, Tateishi R, Chen P-J, Lin S-M, Yoshida H, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int India. 2010;4:439–74.CrossRef Omata M, Lesmana LA, Tateishi R, Chen P-J, Lin S-M, Yoshida H, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int India. 2010;4:439–74.CrossRef
10.
Zurück zum Zitat Arslanoglu A, Seyal AR, Sodagari F, Sahin A, Miller FH, Salem R, et al. Current guidelines for the diagnosis and management of hepatocellular carcinoma: a comparative review. Am J Roentgenol. 2016;207:W88–98.CrossRef Arslanoglu A, Seyal AR, Sodagari F, Sahin A, Miller FH, Salem R, et al. Current guidelines for the diagnosis and management of hepatocellular carcinoma: a comparative review. Am J Roentgenol. 2016;207:W88–98.CrossRef
11.
Zurück zum Zitat •• Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61:1056–65. This paper summarizes the consensus of the LI-RADS management working group that was reached in 2013. CrossRefPubMed •• Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61:1056–65. This paper summarizes the consensus of the LI-RADS management working group that was reached in 2013. CrossRefPubMed
13.
Zurück zum Zitat International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009;49:658–64.CrossRef International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009;49:658–64.CrossRef
14.
Zurück zum Zitat Shah A, Tang A, Santillan C, Sirlin C. Cirrhotic liver: what’s that nodule? The LI-RADS approach. J Magn Reson Imaging. 2016;43:281–94.CrossRefPubMed Shah A, Tang A, Santillan C, Sirlin C. Cirrhotic liver: what’s that nodule? The LI-RADS approach. J Magn Reson Imaging. 2016;43:281–94.CrossRefPubMed
15.
Zurück zum Zitat •• Davenport MS, Khalatbari S, Liu PSC, Maturen KE, Kaza RK, Wasnik AP, et al. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology. 2014;272:132–42. One of the first studies evaluating LI-RADS which looked at inter-reader agreement of the LI-RADS, OPTN, and AASLD as well as the imaging features used in these criteria. CrossRefPubMedPubMedCentral •• Davenport MS, Khalatbari S, Liu PSC, Maturen KE, Kaza RK, Wasnik AP, et al. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology. 2014;272:132–42. One of the first studies evaluating LI-RADS which looked at inter-reader agreement of the LI-RADS, OPTN, and AASLD as well as the imaging features used in these criteria. CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sersté T, Barrau V, Ozenne V, Vullierme M, Bedossa P, Farges O, et al. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology. 2012;55:800–6.CrossRefPubMed Sersté T, Barrau V, Ozenne V, Vullierme M, Bedossa P, Farges O, et al. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology. 2012;55:800–6.CrossRefPubMed
17.
Zurück zum Zitat Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97–104.CrossRefPubMed Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97–104.CrossRefPubMed
18.
Zurück zum Zitat Kim TK, Lee KH, Jang H, Haider MA, Jacks LM, Menezes RJ, et al. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1–2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology. 2011;259:730–8.CrossRefPubMed Kim TK, Lee KH, Jang H, Haider MA, Jacks LM, Menezes RJ, et al. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1–2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology. 2011;259:730–8.CrossRefPubMed
19.
Zurück zum Zitat Jang H-J, Kim TK, Khalili K, Yazdi L, Menezes R, Park SH, et al. Characterization of 1-to 2-cm liver nodules detected on HCC surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary? Am J Roentgenol. 2013;201:314–21.CrossRef Jang H-J, Kim TK, Khalili K, Yazdi L, Menezes R, Park SH, et al. Characterization of 1-to 2-cm liver nodules detected on HCC surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary? Am J Roentgenol. 2013;201:314–21.CrossRef
20.
Zurück zum Zitat Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010;105:599–609.CrossRefPubMed Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010;105:599–609.CrossRefPubMed
21.
Zurück zum Zitat Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59:638–44.CrossRefPubMed Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59:638–44.CrossRefPubMed
22.
Zurück zum Zitat Fowler KJ, Karimova EJ, Arauz AR, Saad NE, Brunt EM, Chapman WC, et al. Validation of Organ Procurement and Transplant Network (OPTN)/United Network for Organ Sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. Transplantation. 2013;95:1506–11.CrossRefPubMed Fowler KJ, Karimova EJ, Arauz AR, Saad NE, Brunt EM, Chapman WC, et al. Validation of Organ Procurement and Transplant Network (OPTN)/United Network for Organ Sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. Transplantation. 2013;95:1506–11.CrossRefPubMed
23.
Zurück zum Zitat ACRIN 6690: a prospective, multicenter comparison of multiphase contrast-enhanced CT and multiphase contrast-enhanced MRI for diagnosis of hepatocellular carcinoma and liver transplant allocation. ACRIN 6690: a prospective, multicenter comparison of multiphase contrast-enhanced CT and multiphase contrast-enhanced MRI for diagnosis of hepatocellular carcinoma and liver transplant allocation.
24.
Zurück zum Zitat Zhang Y-D, Zhu F-P, Xu X, Wang Q, Wu C-J, Liu X-S, et al. Liver imaging reporting and data system: substantial discordance between CT and MR for imaging classification of hepatic nodules. Acad Radiol. 2016;23:344–52.CrossRefPubMed Zhang Y-D, Zhu F-P, Xu X, Wang Q, Wu C-J, Liu X-S, et al. Liver imaging reporting and data system: substantial discordance between CT and MR for imaging classification of hepatic nodules. Acad Radiol. 2016;23:344–52.CrossRefPubMed
25.
Zurück zum Zitat Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, et al. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol. 2016;41:963–9.CrossRef Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, et al. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol. 2016;41:963–9.CrossRef
26.
Zurück zum Zitat Choi SH, Byun JH, Kim SY, Lee SJ, Won HJ, Shin YM, et al. Liver imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol. 2016;51:483–90.CrossRefPubMed Choi SH, Byun JH, Kim SY, Lee SJ, Won HJ, Shin YM, et al. Liver imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol. 2016;51:483–90.CrossRefPubMed
27.
Zurück zum Zitat Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J. Magn. Reson. Imaging. 2016. Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J. Magn. Reson. Imaging. 2016.
28.
Zurück zum Zitat Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, et al. Added value of a gadoxetic acid-enhanced hepatocyte-phase image to the LI-RADS system for diagnosing hepatocellular carcinoma. Magn Reson Med Sci. 2016;15:49–59.CrossRefPubMed Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, et al. Added value of a gadoxetic acid-enhanced hepatocyte-phase image to the LI-RADS system for diagnosing hepatocellular carcinoma. Magn Reson Med Sci. 2016;15:49–59.CrossRefPubMed
29.
Zurück zum Zitat •• Darnell A, Forner A, Rimola J, Reig M, García-Criado Á, Ayuso C, et al. Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology. 2015;275:698–707. One of the first validation studies of LI-RADS which specifically looks as lesion ≤20 mm seen on prior screening US. This paper used v.2013 of LI-RADS and therefore its results have to be reinterpreted in the context of v.2014 as explained in the text. CrossRefPubMed •• Darnell A, Forner A, Rimola J, Reig M, García-Criado Á, Ayuso C, et al. Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology. 2015;275:698–707. One of the first validation studies of LI-RADS which specifically looks as lesion ≤20 mm seen on prior screening US. This paper used v.2013 of LI-RADS and therefore its results have to be reinterpreted in the context of v.2014 as explained in the text. CrossRefPubMed
30.
Zurück zum Zitat Burke LMB, Sofue K, Alagiyawanna M, Nilmini V, Muir AJ, Choudhury KR, et al. Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol. 2016;41:1758–66.CrossRef Burke LMB, Sofue K, Alagiyawanna M, Nilmini V, Muir AJ, Choudhury KR, et al. Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol. 2016;41:1758–66.CrossRef
31.
Zurück zum Zitat Choi J-YY, Cho HC, Sun M, Kim HC, Sirlin CB. Indeterminate observations (Liver Imaging Reporting and Data System category 3) on MRI in the cirrhotic liver: fate and clinical implications. Am J Roentgenol. 2013;201:993–1001.CrossRef Choi J-YY, Cho HC, Sun M, Kim HC, Sirlin CB. Indeterminate observations (Liver Imaging Reporting and Data System category 3) on MRI in the cirrhotic liver: fate and clinical implications. Am J Roentgenol. 2013;201:993–1001.CrossRef
32.
Zurück zum Zitat •• Tanabe M, Kanki A, Wolfson T, Costa EAC, Mamidipalli A, Ferreira MPFD, et al. Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology. 2016;281:129–39. This is the largest paper to date evaluating the natural history of LR-2, LR-3, and LR-4 observations. CrossRefPubMed •• Tanabe M, Kanki A, Wolfson T, Costa EAC, Mamidipalli A, Ferreira MPFD, et al. Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology. 2016;281:129–39. This is the largest paper to date evaluating the natural history of LR-2, LR-3, and LR-4 observations. CrossRefPubMed
33.
Zurück zum Zitat • Bashir MR, Huang R, Mayes N, Marin D, Berg CL, Nelson RC, et al. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging. 2015;42:305–14. This paper shows concordance between LR-5 and OPTN class 5 despite the minimal differences that exist. Patient eligibility for exception points was in near complete agreement between the two systems. CrossRefPubMed • Bashir MR, Huang R, Mayes N, Marin D, Berg CL, Nelson RC, et al. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging. 2015;42:305–14. This paper shows concordance between LR-5 and OPTN class 5 despite the minimal differences that exist. Patient eligibility for exception points was in near complete agreement between the two systems. CrossRefPubMed
34.
Zurück zum Zitat Barth BK, Donati OF, Fischer MA, Ulbrich EJ, Karlo CA, Becker A, et al. Reliability, validity, and reader acceptance of LI-RADS—an in-depth analysis. Acad Radiol. 2016;23:1145–53.CrossRefPubMed Barth BK, Donati OF, Fischer MA, Ulbrich EJ, Karlo CA, Becker A, et al. Reliability, validity, and reader acceptance of LI-RADS—an in-depth analysis. Acad Radiol. 2016;23:1145–53.CrossRefPubMed
35.
Zurück zum Zitat Zhang YD, Zhu FP, Xu X, Wang Q, Wu CJ, Liu XS, et al. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models. J Magn Reson Imaging. 2016;43:373–83.CrossRefPubMed Zhang YD, Zhu FP, Xu X, Wang Q, Wu CJ, Liu XS, et al. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models. J Magn Reson Imaging. 2016;43:373–83.CrossRefPubMed
36.
Zurück zum Zitat Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR. Differences in liver imaging and reporting data system categorization between MRI and CT. Am J Roentgenol. 2016;206:307–12.CrossRef Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR. Differences in liver imaging and reporting data system categorization between MRI and CT. Am J Roentgenol. 2016;206:307–12.CrossRef
37.
Zurück zum Zitat Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996;200:79–84.CrossRefPubMed Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996;200:79–84.CrossRefPubMed
38.
Zurück zum Zitat Hayashida M, Ito K, Fujita T, Shimizu A, Sasaki K, Tanabe M, et al. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Magn Reson Imaging. 2008;26:65–71.CrossRefPubMed Hayashida M, Ito K, Fujita T, Shimizu A, Sasaki K, Tanabe M, et al. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Magn Reson Imaging. 2008;26:65–71.CrossRefPubMed
39.
Zurück zum Zitat Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging. 2001;25:355–61.CrossRefPubMed Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging. 2001;25:355–61.CrossRefPubMed
40.
Zurück zum Zitat Liver lesion initial characterization. American College of Radiology. ACR Appropriateness Criteria. 2005. Liver lesion initial characterization. American College of Radiology. ACR Appropriateness Criteria. 2005.
41.
Zurück zum Zitat Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, et al. Change in liver imaging reporting and data system characterization of focal liver lesions using gadoxetate disodium magnetic resonance imaging compared with contrast-enhanced computed tomography. J Comput Assist Tomogr. 2016. Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, et al. Change in liver imaging reporting and data system characterization of focal liver lesions using gadoxetate disodium magnetic resonance imaging compared with contrast-enhanced computed tomography. J Comput Assist Tomogr. 2016.
Metadaten
Titel
Understanding LI-RADS, Its Relationship to AASLD and OPTN, and the Challenges of Its Adoption
verfasst von
Joseph H. Yacoub
Frank H. Miller
Publikationsdatum
21.02.2017
Verlag
Springer US
Erschienen in
Current Hepatology Reports / Ausgabe 1/2017
Elektronische ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-017-0337-y

Weitere Artikel der Ausgabe 1/2017

Current Hepatology Reports 1/2017 Zur Ausgabe

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Changes in Liver Transplant Criteria for Hepatocellular Carcinoma

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Racial/Ethnic Disparities in Hepatocellular Carcinoma Epidemiology

Hepatitis C (J Ahn and A Aronsohn, Section Editors)

Treatment of Hepatitis C in Children

Hepatitis C (J Ahn and A Aronsohn, Section Editors)

Use of Hepatitis C-Positive Donor Livers in Liver Transplantation

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Advances in Pediatric Liver Tumors

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.